Skip to main content

Basel areas hold promise for investors

| News

Basel areas hold promise for investors

28.11.2019

Substantial efforts are underway in Basel to develop new areas and create space for people and companies. The efforts were welcomed by investors at the 17th Basler Investorengespräch.

The project Nordspitze exists for the area Dreispitz Nord (visualization: Herzog & de Meuron)

The 17th Basler Investorengespräch was held at the Kunstmuseum in Basel, according to the canton of Basel-Stadt. Executive Council President Elisabeth Ackermann welcomed 140 invited guests from across Switzerland who had sought to find out about the development of areas in Basel.

Occupying a total of 113 hectares, the areas under transformation are in central locations. In the coming 10 to 20 years, they will be developed with new living and working quarters in Basel’s effort to prepare for growth. The projects will create space for 20,000 new inhabitants and 30,000 jobs by 2035, confirmed Member of the Government of Basel-Stadt Hans-Peter Wessels in his speech.

Member of the Government Eva Herzog spoke about the research and administration site Areal Rosental Mitte, which is currently being transformed into a public quarter. There are plans to connect work with research and living space here, granting development opportunities to both companies in Basel and companies moving to the region. Lukas Ott, who heads cantonal and urban development in Basel-Stadt, also spoke about the variety of development across the areas. He said, Basel would do well to “develop its valuable transformation spaces gradually, flexibly and in a variety of ways”.

The event was rounded off by a panel about development in a rapidly changing market. Participants included cantonal architect Beat Aeberhard; the director of Immobilien Basel-Stadt, Rolf Borner; the head of development at SBB Immobilien, Susanne Zenker; and the CEO of Central Real Estate Basel AG, Andreas Fürst.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Forty51 Ventures invests to found Mysthera Therapeutics

Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided...
Read More

Spexis receives capital commitment of 2.5 million US dollars

Investors have made an additional capital commitment to Spexis AG, based in the Basel Area. With an extra 2.5 million...
Read More

Worg secures financing of 130 million Swiss francs

The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent...
Read More

Tenpoint aims to make vision loss reversible

The startup Tenpoint Therapeutics has started operations with a funding round of 70 million US dollars. It works to make...
Read More

Roche and ETH training the next generation of researchers

Roche, the Basel-based life sciences firm, and the Swiss Federal Institute of Technology in Zurich (ETH) are joining forces to...
Read More

Clear Solutions Labs seeks to benefit from the Basel Area

The founders of Clear Solutions Laboratories are putting together a team of experts in the fields of biotechnology, pharmaceutical science...
Read More

QuantumBasel offers access to the world’s most powerful quantum computers

QuantumBasel has consolidated its status as a neutral quantum hub with access to the world’s best quantum computers through a...
Read More

How digital transformation is driving pharmaceutical innovation in Basel

How are digital innovations such as artificial intelligence (AI) and machine learning (ML) helping to improve drug research and development?...
Read More

Medical informatics is shaping Switzerland’s digital future

Switzerland is at the forefront of embracing medical informatics, and innovative biotech hubs – such as the Basel Area –...
Read More

Ground-breaking oncology being developed in the Basel Area

The Basel Area – covering northwestern Switzerland – has seen tremendous growth in recent years, and has become a true...
Read More

Genedata expanding its user network

The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site...
Read More

How Moderna is growing in Switzerland

The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...
Read More

Sandoz decides on Basel for headquarters

Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...
Read More

VectivBio sold for approximately 1 billion dollars

The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read More
1 2 3 12

Do you have a question? We'd like to hear from you.